Market for CBD-based pain relief products is growing rapidly, projected to reach $20 billion by 2024 CNSC is a biotech company that produces fast-acting CBD products under the Xceptol brand Xceptol products are formulated with exclusive technology that increases absorbability, bioavailability, shelf life Third-party testing on Xceptol suggests 400% increase in skin penetration, 300% increase … Continue reading “CannAssist International Corp.’s (CNSC) Proprietary CiBiDinol Technology Promises to Outperform Conventional CBD Oil for Superior Pain-Relief”
CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach. CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology. IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community. Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: … Continue reading “CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions”
CannAssist (OTCQB: CNSC) today announced approval of its Xceptol brand on the distribution website RangeMe. According to the update, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available, bringing the number of Xceptol SKUs on the platform to 10. Additional SKUs will be added in the first quarter of 2021. … Continue reading “CannabisNewsBreaks – CannAssist International Corporation’s (CNSC) Xceptol Brand Available via Innovative Distribution Portal – RangeMe”
CannAssist (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand. A recent article discussing the company reads, “Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary … Continue reading “CannabisNewsBreaks – Why CannAssist International Corporation (CNSC) Is ‘One to Watch’”
CannAssist International’s Xceptor Labs is active player within CBD-based product sector Global CBD product market is expected to rise in value from $4.6 billion in 2018 to over $23 billion by 2025 Xceptor Labs differentiating product range through use, development of proprietary CiBiDinol technology CiBiDinol technology covers the oil soluble CBD molecule with a water … Continue reading “CannAssist International (CNSC) Prepares to Take CBD Product Market by Storm”
CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently announced SEC approval of its Reg. A+ Tier 2 Filing as of Oct. 13, 2020, and an opportunity for investors to purchase shares at a set price stated in filing. “CannAssist International is building digital platforms, implementing a Brand PR and Sales/Marketing Campaign, expanding distribution, … Continue reading “CannabisNewsBreaks – CannAssist International Corporation’s (CNSC) Reg. A Offering Capital to Boost Continued Brand Expansion, Benchmarks”
In July 2020, CannAssist International became among the first U.S.-based CBD companies to have its securities listed for trading onto a U.S. public capital market Xceptor Labs uses proprietary technology to create CBD products that it believes have better absorption than currently marketed oil-based products The company currently has five creams that utilize ingredients with … Continue reading “CannAssist International Corp. (CNSC) Is ‘One to Watch’”
CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently commenced trading on the OTC Markets Platform – OTCQB Markets Tier. “Our Team has been working diligently for years to get to where we are now. Third party testing has revealed that our proprietary process used in our products can facilitate enhanced absorbency of CBD … Continue reading “CannabisNewsBreaks – CannAssist International Corporation (CNSC) Commences Trading on the OTCQB”
The 2018 Farm Bill legalized the cultivation and sale of industrial hemp and hemp extracts, including cannabidiol (“CBD”), spawning what would soon be one of the most popular health and wellness ingredients in a long time. With both hemp and CBD boasting a wide array of benefits, a market products containing the two ingredients sprang … Continue reading “420 with CNW — New Congressional Bill Could Allow CBD, Hemp to Be Sold as Dietary Supplements”
A report from a team of researchers from the University of Australia, published in “Nature,” has demonstrated how synthetic cannabidiol (“CBD”) can eliminate various bacteria responsible for ailments such as Legionnaires’ disease, meningitis and gonorrhea. The report suggests that CBD could bring about a class of new antibiotics for resistant bacteria in a few decades … Continue reading “420 with CNW — CBD May Be the Remedy for Gonorrhea and Other Bacterial Diseases”
